BIOCRYST PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Share-based Payment Arrangement, Expense of $14.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $14.69M, a 31.04% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $23.79M, a 11.50% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $18.60M, a 7.84% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $21.30M, a 61.72% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2025 was $85.07M, a 30.04% increase from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2024 was $65.41M, a 17.62% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2023 was $55.62M, a 24.42% increase from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2022 was $44.70M, a 29.04% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $14.69M 10-Q · filed 2026-08-05 | $30.72M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $23.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.39M derived: sum of 2 quarters · filed 2026-02-26 | $63.70M derived: sum of 3 quarters · filed 2026-08-05 | $85.07M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $18.60M 10-Q · filed 2025-11-04 | $39.91M derived: sum of 2 quarters · filed 2026-08-05 | $61.27M 10-Q · filed 2025-11-04 | $82.61M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $21.30M 10-Q · filed 2026-08-05 | $42.67M 10-Q · filed 2026-08-05 | $64.01M derived: sum of 3 quarters · filed 2026-08-05 | $81.26M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $21.37M 10-Q · filed 2025-05-06 | $42.71M derived: sum of 2 quarters · filed 2026-02-26 | $59.96M derived: sum of 3 quarters · filed 2026-02-26 | $73.13M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $21.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.59M derived: sum of 2 quarters · filed 2026-02-26 | $51.76M derived: sum of 3 quarters · filed 2026-02-26 | $65.41M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $17.25M 10-Q · filed 2025-11-04 | $30.42M derived: sum of 2 quarters · filed 2025-11-04 | $44.07M 10-Q · filed 2025-11-04 | $60.56M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $13.17M 10-Q · filed 2025-08-05 | $26.82M 10-Q · filed 2025-08-05 | $43.31M derived: sum of 3 quarters · filed 2026-02-26 | $55.59M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $13.65M 10-Q · filed 2025-05-06 | $30.14M derived: sum of 2 quarters · filed 2026-02-26 | $42.42M derived: sum of 3 quarters · filed 2026-02-26 | $55.26M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $16.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.77M derived: sum of 2 quarters · filed 2026-02-26 | $41.61M derived: sum of 3 quarters · filed 2026-02-26 | $55.62M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $12.28M 10-Q · filed 2024-11-05 | $25.12M derived: sum of 2 quarters · filed 2024-11-05 | $39.13M 10-Q · filed 2024-11-05 | $54.41M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-06-30 | $12.84M 10-Q · filed 2024-08-06 | $26.85M 10-Q · filed 2024-08-06 | $42.13M derived: sum of 3 quarters · filed 2025-02-25 | $52.08M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2023-03-31 | $14.01M 10-Q · filed 2024-05-07 | $29.29M derived: sum of 2 quarters · filed 2025-02-25 | $39.24M derived: sum of 3 quarters · filed 2025-02-25 | $49.11M derived: sum of 4 quarters · filed 2025-02-25 | |
| 2022-12-31 | $15.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $25.23M derived: sum of 2 quarters · filed 2025-02-25 | $35.10M derived: sum of 3 quarters · filed 2025-02-25 | $44.70M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $9.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $19.82M derived: sum of 2 quarters · filed 2023-11-08 | $29.42M 10-Q · filed 2023-11-08 | $37.92M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $9.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $19.47M 10-Q · filed 2023-08-07 | $27.97M derived: sum of 3 quarters · filed 2024-02-27 | $41.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $9.60M 10-Q · filed 2023-05-08 | $18.10M derived: sum of 2 quarters · filed 2024-02-27 | $31.13M derived: sum of 3 quarters · filed 2024-02-27 | $38.76M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $21.53M derived: sum of 2 quarters · filed 2024-02-27 | $29.16M derived: sum of 3 quarters · filed 2024-02-27 | $34.64M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $13.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $20.66M derived: sum of 2 quarters · filed 2022-11-04 | $26.14M 10-Q · filed 2022-11-04 | $32.03M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $13.11M 10-Q · filed 2022-08-05 | $19.00M derived: sum of 3 quarters · filed 2023-02-27 | $21.87M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $5.48M 10-Q · filed 2022-05-09 | $11.37M derived: sum of 2 quarters · filed 2023-02-27 | $14.24M derived: sum of 3 quarters · filed 2023-02-27 | $17.52M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $8.76M derived: sum of 2 quarters · filed 2023-02-27 | $12.04M derived: sum of 3 quarters · filed 2023-02-27 | $14.79M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.15M derived: sum of 2 quarters · filed 2021-11-04 | $8.91M 10-Q · filed 2021-11-04 | $12.60M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $3.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $6.03M 10-Q · filed 2021-08-09 | $9.72M derived: sum of 3 quarters · filed 2022-02-28 | $15.05M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | $2.75M 10-Q · filed 2021-05-07 | $6.44M derived: sum of 2 quarters · filed 2022-02-28 | $11.77M derived: sum of 3 quarters · filed 2022-02-28 | $17.16M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.02M derived: sum of 2 quarters · filed 2022-02-28 | $14.40M derived: sum of 3 quarters · filed 2022-02-28 | $17.72M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.71M derived: sum of 2 quarters · filed 2020-11-06 | $14.03M 10-Q · filed 2020-11-06 | $16.36M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $5.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $8.70M 10-Q · filed 2020-08-07 | $11.03M derived: sum of 3 quarters · filed 2021-03-01 | $13.11M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $3.32M 10-Q · filed 2020-05-11 | $5.64M derived: sum of 2 quarters · filed 2021-03-01 | $7.73M derived: sum of 3 quarters · filed 2021-03-01 | $9.81M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.41M derived: sum of 2 quarters · filed 2021-03-01 | $6.49M derived: sum of 3 quarters · filed 2021-03-01 | $9.40M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $4.17M derived: sum of 2 quarters · filed 2019-11-08 | $7.07M 10-Q · filed 2019-11-08 | $9.39M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $4.99M 10-Q · filed 2019-08-08 | $7.30M derived: sum of 3 quarters · filed 2020-03-13 | $12.82M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-03-31 | $2.90M 10-Q · filed 2019-05-09 | $5.22M derived: sum of 2 quarters · filed 2020-03-13 | $10.74M derived: sum of 3 quarters · filed 2020-03-13 | $13.06M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2017-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $7.83M derived: sum of 2 quarters · filed 2020-03-13 | $10.16M derived: sum of 3 quarters · filed 2020-03-13 | $12.62M 10-K · filed 2020-03-13 | |
| 2017-09-30 | $5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $7.84M derived: sum of 2 quarters · filed 2018-11-08 | $10.31M 10-Q · filed 2018-11-08 | $12.32M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.79M 10-Q · filed 2018-08-09 | $6.80M derived: sum of 3 quarters · filed 2019-03-14 | $8.78M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $2.46M 10-Q · filed 2018-05-09 | $4.47M derived: sum of 2 quarters · filed 2019-03-14 | $6.46M derived: sum of 3 quarters · filed 2019-03-14 | $10.95M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.00M derived: sum of 2 quarters · filed 2019-03-14 | $8.48M derived: sum of 3 quarters · filed 2019-03-14 | $8.49M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $6.48M derived: sum of 2 quarters · filed 2017-11-08 | $6.48M 10-Q · filed 2017-11-08 | $8.41M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | $4.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $4.49M 10-Q · filed 2017-08-08 | $6.42M derived: sum of 3 quarters · filed 2018-03-12 | $8.26M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | $2.65K 10-Q · filed 2017-05-08 | $2.65M 10-Q · filed 2016-05-09 | $1.93M derived: sum of 2 quarters · filed 2018-03-12 | $3.77M derived: sum of 3 quarters · filed 2018-03-12 | $7.45M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $3.77M derived: sum of 2 quarters · filed 2018-03-12 | $7.45M derived: sum of 3 quarters · filed 2018-03-12 | $9.71M 10-K · filed 2018-03-12 | |
| 2015-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $5.51M derived: sum of 2 quarters · filed 2016-11-08 | $7.77M 10-Q · filed 2016-11-08 | $11.40M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $5.93M 10-Q · filed 2016-08-08 | $9.56M derived: sum of 3 quarters · filed 2017-02-27 | $10.98M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $2.26M 10-Q · filed 2016-05-09 | $5.89M derived: sum of 2 quarters · filed 2017-02-27 | $7.31M derived: sum of 3 quarters · filed 2017-02-27 | $10.83M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $5.05M derived: sum of 2 quarters · filed 2017-02-27 | $8.57M derived: sum of 3 quarters · filed 2017-02-27 | $10.18M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.94M derived: sum of 2 quarters · filed 2015-11-06 | $6.55M 10-Q · filed 2015-11-06 | $7.44M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $5.13M 10-Q · filed 2015-08-07 | $6.02M derived: sum of 3 quarters · filed 2016-02-26 | $6.98M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-03-31 | $1.61M 10-Q · filed 2015-05-08 | $2.50M derived: sum of 2 quarters · filed 2016-02-26 | $3.46M derived: sum of 3 quarters · filed 2016-02-26 | ||
| 2013-12-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $1.85M derived: sum of 2 quarters · filed 2016-02-26 | $4.37M 10-K · filed 2016-02-26 | ||
| 2013-09-30 | $958.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.48M 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $2.52M 10-Q · filed 2014-08-08 | ||||
| 2012-12-31 | $4.17M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |